Triamcinolone Hexacetonide
FDA-approved product (injectable, injection), marketed as Aristospan.
- Registered studies
- 50+
- Lab records
- 0
- Pathogens at ≥40%
- 1 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLApproved for
- Airway obstruction
- Eye inflammation
- Hemorrhoid
- Nasal congestion
- Osteoarthritis
- Skin disease
Indications ChEMBL records as approved, from FDA and DailyMed labels. Label ↗
- WHO therapeutic group
- Corticosteroids for local oral treatment; Corticosteroids; Corticosteroids, moderately potent (group ii); Corticosteroids, moderately potent, other combinations; Glucocorticoids
- Anti-infective classification
- Not classified as an anti-infective.
Repurposing investigation
This medicine is being investigated here for AI-predicted antimicrobial activity against MRSA. It was surfaced computationally for further investigation; it is not an established treatment for this infection.
AI-predicted activity
AI prediction · nothing measured- MRSA53.1% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
- E. coli36.6% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- K. pneumoniae28.3% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- M. tuberculosis36.1% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredAutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Triamcinolone Hexacetonide with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- Galantamine HydrobromideExisting use: Alzheimer disease, Dementia89.6% AI-predicted activityagainst K. pneumoniaeLab records exist50+ registered studies
- Chlorhexidine GluconateExisting use: Eye infection, Gingivitis, Infection and 2 more69.3% AI-predicted activityagainst K. pneumoniaeLab records exist50+ registered studies
- TriclosanExisting use: Phenol and derivatives, Medicated dressings with antiinfectives68.0% AI-predicted activityagainst K. pneumoniaeLab records exist50+ registered studies
- ElvitegravirExisting use: HIV infection, HIV-1 infection, Viral disease60.2% AI-predicted activityagainst K. pneumoniae50+ registered studies
- Caspofungin AcetateExisting use: Aspergillosis, Candidemia, Candidiasis and 1 more57.5% AI-predicted activityagainst K. pneumoniae50+ registered studies
- DactinomycinExisting use: Kidney Wilms tumor, Neoplasm56.8% AI-predicted activityagainst K. pneumoniae50+ registered studies
- CyclosporineExisting use: Conjunctivitis, Corneal disease, Eye disease and 6 more56.1% AI-predicted activityagainst K. pneumoniae50+ registered studies
- LinaclotideExisting use: Constipation, Constipation disorder, Irritable bowel syndrome56.0% AI-predicted activityagainst K. pneumoniae50+ registered studies
- Irinotecan HydrochlorideExisting use: Adenocarcinoma, Cancer, Carcinoma and 4 more54.5% AI-predicted activityagainst K. pneumoniae50+ registered studies
- OxytocinExisting use: Hemorrhage, Uterine Inertia52.7% AI-predicted activityagainst K. pneumoniae50+ registered studies
- Micafungin SodiumExisting use: Candidiasis52.4% AI-predicted activityagainst K. pneumoniae50+ registered studies
- VoclosporinExisting use: Immune system disease, Lupus nephritis52.2% AI-predicted activityagainst K. pneumoniae28 registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Dexmedetomidine Versus Triamcinolone Treatment of Carpal Tunnel Syndrome
NCT04961281 · start 2021-07-22
Registered record
- Registry ID
- NCT04961281
- Conditions
- Chronic Pain; Carpal Tunnel Syndrome
- Interventions
- Dexmedetomidine; Triamcinolone
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2021-07-22
- Completion
- 2022-08-01
- Enrolment
- 60
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionChronic Pain; Carpal Tunnel SyndromeInterventionDexmedetomidine; TriamcinolonePhaseNot applicableRegistry statusCompletedCell Therapy With Cellistem-OA for Symptomatic Knee Osteoarthritis
NCT04863183 · start 2021-06-01
Registered record
- Registry ID
- NCT04863183
- Conditions
- Mesenchymal Stem Cells; Knee Osteoarthritis; Cell Therapy
- Interventions
- CELLISTEM-OA; Triamcinolone acetonide
- Study type
- INTERVENTIONAL
- Phase
- Phase 1 / Phase 2
- Registry status
- Unknown
- Start
- 2021-06-01
- Completion
- 2022-06-30
- Enrolment
- 30
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMesenchymal Stem Cells; Knee Osteoarthritis; Cell TherapyInterventionCELLISTEM-OA; Triamcinolone acetonidePhasePhase 1 / Phase 2Registry statusUnknownEffect of Zilretta Injection
NCT04261049 · start 2020-08-01
Registered record
- Registry ID
- NCT04261049
- Conditions
- Osteoarthritis, Knee
- Interventions
- Triamcinolone Acetonide Extended-Release Injectable Suspension
- Study type
- INTERVENTIONAL
- Phase
- Phase 1
- Registry status
- Completed
- Start
- 2020-08-01
- Completion
- 2022-01-10
- Enrolment
- 35
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionOsteoarthritis, KneeInterventionTriamcinolone Acetonide Extended-Release Injectable SuspensionPhasePhase 1Registry statusCompletedFractional Microneedling RF vs Intralesional Steroid With & Without Microneedling in Hypertrophic Scars
NCT04389619 · start 2020-05-10
Registered record
- Registry ID
- NCT04389619
- Conditions
- Hypertrophic Scars
- Interventions
- Fractional Microneedling Radiofrequency; Intralesional Steroid Injection with and without Microneedling
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2020-05-10
- Completion
- 2020-12
- Enrolment
- 30
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHypertrophic ScarsInterventionFractional Microneedling Radiofrequency; Intralesional Steroid Injection with and without MicroneedlingPhaseNot applicableRegistry statusUnknownSuprachoroidal Triamcinolone Versus Posterior Subtenon Triamcinolone Alone or Formulated in the Management of Diabetic Macular Edema.
NCT05464953 · start 2020-01-20
Registered record
- Registry ID
- NCT05464953
- Conditions
- Diabetic Macular Edema of Left Eye
- Interventions
- Triamcinolone Acetonide; Formulated Triamcinolone
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2020-01-20
- Completion
- 2022-04-30
- Enrolment
- 75
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionDiabetic Macular Edema of Left EyeInterventionTriamcinolone Acetonide; Formulated TriamcinolonePhaseNot applicableRegistry statusCompletedIncreased Blood Glucose Levels After Steroid Injection
NCT06228911 · start 2020-01-15
Registered record
- Registry ID
- NCT06228911
- Conditions
- Osteoarthritis, Knee; Diabete Type 2
- Interventions
- steroid (triamcinolone)
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2020-01-15
- Completion
- 2023-09-15
- Enrolment
- 600
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionOsteoarthritis, Knee; Diabete Type 2Interventionsteroid (triamcinolone)PhaseNot applicableRegistry statusCompletedSteroid-reducing Effects of Crisaborole
NCT03832010 · start 2019-12-17
Registered record
- Registry ID
- NCT03832010
- Conditions
- Atopic Dermatitis; Eczema
- Interventions
- Crisaborole; Hydrocortisone Ointment; Triamcinolone ointment; Aquaphor
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2019-12-17
- Completion
- 2024-02-16
- Enrolment
- 24
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAtopic Dermatitis; EczemaInterventionCrisaborole; Hydrocortisone Ointment; Triamcinolone ointment; AquaphorPhasePhase 4Registry statusCompletedThe Efficacy of Topical Sesame Oil Versus Topical Triamcinolone on Oral Lichen Planus and Salivary Level of Oxidative Stress Biomarker [MDA]
NCT03738176 · start 2019-12-16
Registered record
- Registry ID
- NCT03738176
- Conditions
- Oral Lichen Planus
- Interventions
- Sesame Oil; triamcinolone in orabase
- Study type
- INTERVENTIONAL
- Phase
- Early phase 1
- Registry status
- Unknown
- Start
- 2019-12-16
- Completion
- 2020-12-30
- Enrolment
- 40
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionOral Lichen PlanusInterventionSesame Oil; triamcinolone in orabasePhaseEarly phase 1Registry statusUnknownThe Use of Suprachoroidal Triamcinolone Acetonide to Treat Macular Edema in Retinal Vein Occlusion
NCT05038072 · start 2019-07-25
Registered record
- Registry ID
- NCT05038072
- Conditions
- Macular Edema; Retinal Vein Occlusion
- Interventions
- suprachoroidal injection of Triamcinolone Acetonide.
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2019-07-25
- Completion
- 2021-02-28
- Enrolment
- 16
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMacular Edema; Retinal Vein OcclusionInterventionsuprachoroidal injection of Triamcinolone Acetonide.PhaseNot applicableRegistry statusCompletedUltrasound-guided Intervention and Hand Tenosynovitis in Patients With Diabetes Mellitus
NCT03789526 · start 2018-12-11
Registered record
- Registry ID
- NCT03789526
- Conditions
- Ultrasound Guided Injection
- Interventions
- ultrasound guidance
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2018-12-11
- Completion
- 2019-02-01
- Enrolment
- 52
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionUltrasound Guided InjectionInterventionultrasound guidancePhaseNot applicableRegistry statusCompletedThe Effect of Micro Fragmented Adipose Tissue (MFAT) on Knee Osteoarthritis
NCT03467919 · start 2018-04-01
Registered record
- Registry ID
- NCT03467919
- Conditions
- Osteoarthritis, Knee; Knee Pain
- Interventions
- Micro Fragmented Adipose Tissue; Corticosteroid injection
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2018-04-01
- Completion
- 2024-10-29
- Enrolment
- 40
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionOsteoarthritis, Knee; Knee PainInterventionMicro Fragmented Adipose Tissue; Corticosteroid injectionPhasePhase 3Registry statusCompletedKybella With Triamcinolone
NCT03361176 · start 2018-03-26
Registered record
- Registry ID
- NCT03361176
- Conditions
- Adiposity
- Interventions
- Injectable sodium deoxycholate; Injectable sodium deoxycholate with Triamcinolone acetate
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2018-03-26
- Completion
- 2018-12-18
- Enrolment
- 30
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAdiposityInterventionInjectable sodium deoxycholate; Injectable sodium deoxycholate with Triamcinolone acetatePhasePhase 4Registry statusCompletedGene Expression and Biomarker Profiling of Keloid Skin
NCT03228693 · start 2017-09-11
Registered record
- Registry ID
- NCT03228693
- Conditions
- Keloid; Keloid of Ear Lobe; Healthy Adults
- Interventions
- Biopsy and/or triamcinolone injection; Excisional Biopsy
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2017-09-11
- Completion
- 2023-01-31
- Enrolment
- 48
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionKeloid; Keloid of Ear Lobe; Healthy AdultsInterventionBiopsy and/or triamcinolone injection; Excisional BiopsyPhaseNot applicableRegistry statusCompletedAsthma Research in Children and Adolescents
NCT04480242 · start 2017-07-26
Registered record
- Registry ID
- NCT04480242
- Conditions
- Persistent Asthma; Asthma in Children; Asthma Exacerbation
- Interventions
- Inhaled Corticosteroids (ICs); Fixed-Dose Combination of Inhaled Corticosteroids and Long- Acting Beta-agonist (ICs/LABA); Other treatments; Inhaler device; Regularly monitoring of the Inhalation technique through mobile app
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Active not recruiting
- Start
- 2017-07-26
- Completion
- 2030-12-31
- Enrolment
- 525
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPersistent Asthma; Asthma in Children; Asthma ExacerbationInterventionInhaled Corticosteroids (ICs); Fixed-Dose Combination of Inhaled Corticosteroids and Long- Acting Beta-agonist (ICs/LABA); Other treatments; Inhaler device +1 morePhaseNot recordedRegistry statusActive not recruitingStandardized and Modified Corticosteroid Subacromial Injection for Shoulder Impingement Syndrome
NCT03148353 · start 2017-05-30
Registered record
- Registry ID
- NCT03148353
- Conditions
- Shoulder Impingement
- Interventions
- Subacromial injection
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2017-05-30
- Completion
- 2018-10-01
- Enrolment
- 60
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionShoulder ImpingementInterventionSubacromial injectionPhaseNot applicableRegistry statusCompleted